CAJ | 학술논문

曲美他嗪也称为TMZ，该药物在研发初期，由于其耐受性较好，因此一般用在抗心绞痛患者的临床治疗中。而随着医疗技术的不断发展，通过研究发现，TMZ还能够有效保护缺血心肌。而一般的药物对患者的血流动力学影响较明显，因此TMZ的代谢环节就成为了医学界研究的焦点，对其治疗心血管疾病的临床效果进行回顾分析，能够在实践中指导临床工作。
곡미타진야칭위TMZ，해약물재연발초기，유우기내수성교호，인차일반용재항심교통환자적림상치료중。이수착의료기술적불단발전，통과연구발현，TMZ환능구유효보호결혈심기。이일반적약물대환자적혈류동역학영향교명현，인차TMZ적대사배절취성위료의학계연구적초점，대기치료심혈관질병적림상효과진행회고분석，능구재실천중지도림상공작。
Trimetazidine also called TMZ, early in the development of the drug, because of its well tolerated, it is generally used in clinical antianginal therapy. With medical technology continues to develop, through the study found, TMZ is also able to effectively protect the ischemic myocardium. And general drugs on hemodynamics in patients with more pronounced, so TMZ metabolic aspects of the medical profession has become the focus of research, its clinical effect of the treatment of cardiovascular disease were analyzed retrospectively, to guide clinical work in practice.